TikaMobile, Inc
Contact Us
PharmaTimes: News RSS
- Scancell picks lead COVID-19 vaccine candidate
- GSK co-leads investment in ‘disease rebalancing’ Adrestia Therapeutics
- Novo Nordisk eyes EU approval for once-weekly semaglutide
- NHS England invests £10m in network of ‘long COVID’ clinics
- PharmaTimes are excited to announce the launch of INTCR 2021
- EUSA Pharma launches phase III COVID-19 study for siltuximab
- International consortium creates ‘open platform’ for COVID-19 drug discovery
- Gilead's CAR T therapy Tecartus authorised in EU for MCL
- Valneva starts UK-based early-stage COVID-19 vaccine trial
- New research reveals impact of childhood type 1 diabetes on mental health